Derrick

Derrick

@dgingery

Followers881
Following505

An Indiana Hoosiers fan, news junkie, health care journalist @PharmaPinkSheet and soon a novelist. Opinions are my own.

Maryland
Joined on October 11, 2008

Statistics

We looked inside some of the tweets by @dgingery and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
3 hours
Average replies
0
Average retweets
0
Average likes
0
Tweets with photos
0 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100

Last Seen Profiles

@UZI383@UZI383
@UnicornLyna@UnicornLyna
@NightmaresVeng2@NightmaresVeng2
@hotoddeok@hotoddeok
@nmhathletics@nmhathletics
@shinwa_taso@shinwa_taso
@oboykin_ru@oboykin_ru
@KateleenLim@KateleenLim
@BanuTaranci@BanuTaranci
@rguptaji@rguptaji
@akitacatanclub@akitacatanclub
@obsesifhatus@obsesifhatus
@chispina@chispina
@black_out972@black_out972
@S_Moh43@S_Moh43
@mnnkpr@mnnkpr
Derrick
28 minutes ago

Quoted @BiosimCenter

In an interview with The Center for Biosimilars, Mona Chitre, PharmD, CGP, of Excellus Blue Cross Blue Shield, says that employers are beginning to buy in around the concept of biosimilar competition. “It may take time, and it’s okay that we’re the first.” http://ow.ly/DB3a30nMF5T 

This seems like a positive development for #biosimilar uptake...

Today, the FDA issued a safety announcement regarding an increased risk of mortality with a drug that is prescribed for gout. FDA is now requiring a Boxed Warning on the drug label and a new patient Medication Guide. https://go.usa.gov/xEmEa 

Derrick
8 hours ago

Check this out too: #FDA Final Rule Places Six Substances On 503A Bulks List; Rejects Four

Derrick
8 hours ago

Even more Thursday reading: Patent Settlements: #FTC Gets Teva To Eschew 'No-Authorized Generic' Deals

Derrick
8 hours ago

Bonus Thursday reading: Rx Spending Growth To Be Driven By New Drug Entries, #CMS Says

Derrick
8 hours ago

More Thursday reading: Insulin Maker Lilly Seeks US #FDA Assurances On ‘Authorized Biologics’

Derrick
8 hours ago

Thursday morning reading: Pediatric Exclusivity For ‘Deemed’ Biologics Needs Clarity, Industry Tells US #FDA

Derrick
8 hours ago

Quoted @eyeonfda

#FDA issues proposed rule that would update regulatory requirements for most # http://ow.ly/xp0f30nMFsX  sunscreen products

My colleagues at @HBWInsight are working on this now...

Quoted @Pharma_Intell

It is one week to go until our industry analysts discuss their data-based views on what is in-store for key drugs in 2019! Join us next week http://bit.ly/2sWVVS2 

It is one week to go until our industry analysts discuss their data-based views on what is in-store for key drugs in 2019! Join us next week http://bit.ly/2sWVVS2 

Check this out...

And this...How One Biotech Venture Is Breaking The Cost Barrier In Manufacturing MAbs For Infectious Diseases

Check this out too: Can Government Petition PTAB To Review Patents? Supreme Court Seems Skeptical

Here's part 1 in case you missed it:

Part 2 of our story on the #FDA competitive generic therapy guidance:

More Wednesday reading: Annuity Payment Model For Cures May Get Test Drive In Massachusetts

Snow day reading: Rare Pediatric Disease Priority Review Voucher Not Generating New Drug Trials

Strong evidence for @US_FDA to follow the international consensus by dropping #biosimilar suffixes.

Quoted @WhiteHouse

This Administration is expediting the review and approval of generic drugs in order to deliver real price reductions and better healthcare access to American patients.

This Administration is expediting the review and approval of generic drugs in order to deliver real price reductions and better healthcare access to American patients.

The #FDA commish @SGottliebFDA says agency will expedite generic applications until three approved to help bring down prices...

Quoted @brendasandburg

#SupremeCourt denies Frosh v. AAM cert petition challenging 4th Circuit ruling that Maryland's Anti-Price Gouging Act violates Constitution's Commerce clause, and denies Mylan v. UCB petition seeking review of Federal Circuit's approach to obviousness-type double-patenting $MYL

Interesting...

Quoted @PharmaPinkSheet

France Invites Advanced Therapy Makers To Use Fast-Track Trial Approval Pathway http://bit.ly/2trKWQT  #PinkSheet

And this...

Quoted @Medtech_Insight

MDx Health Names New CEO http://bit.ly/2tup5sc  #Medtech

Check this out...

Next Page